Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Gulati

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Respiratory Medicine Case Reports|May 2, 2017
Mesalamine induced eosinophilic pneumoniaAnkit Gupta, Swati Gulati
Drug, Healthcare and Patient Safety|May 23, 2020
Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary FibrosisSwati Gulati, Tracy R Luckhardt
Drugs|March 4, 2017
Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent ExacerbatorsSwati Gulati, J Michael Wells
The American Journal of the Medical Sciences|April 24, 2019
The Aging Lung and Idiopathic Pulmonary FibrosisSwati Gulati, Victor J Thannickal
Translational Lung Cancer Research|March 26, 2015
Lung cancer screening guidelines: common ground and differencesSwati Gulati, James L Mulshine
Plos One|February 21, 2020
Pulmonary artery enlargement is associated with pulmonary hypertension and decreased survival in severe cystic fibrosis: A cohort studyAline N Zouk, Swati Gulati, Dongqi Xing, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 11, 2019
Velocity Transfer Function In The Right Pulmonary Artery And Impaired Cardiopulmonary Reserve In COPDOleg F Sharifov, Thomas S Denney, J Michael Wells, et al.
International Journal of Molecular Sciences|May 12, 2019
Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot StudySwati Gulati, J Michael Wells, Gisel P Urdaneta, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 14, 2018
The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort studySwati Gulati, Aline N Zouk, Jonathan P Kalehoff, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 28, 2023
Evaluating the consistency with guideline recommendations for diagnosis and management of idiopathic pulmonary fibrosis in non-academic settingsJoao De Andrade, Tracy Luckhardt, Sushilkumar Sonavane, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Respiratory Medicine Case Reports|May 2, 2017
Mesalamine induced eosinophilic pneumoniaAnkit Gupta, Swati Gulati
Drug, Healthcare and Patient Safety|May 23, 2020
Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary FibrosisSwati Gulati, Tracy R Luckhardt
Drugs|March 4, 2017
Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent ExacerbatorsSwati Gulati, J Michael Wells
The American Journal of the Medical Sciences|April 24, 2019
The Aging Lung and Idiopathic Pulmonary FibrosisSwati Gulati, Victor J Thannickal
Translational Lung Cancer Research|March 26, 2015
Lung cancer screening guidelines: common ground and differencesSwati Gulati, James L Mulshine
Plos One|February 21, 2020
Pulmonary artery enlargement is associated with pulmonary hypertension and decreased survival in severe cystic fibrosis: A cohort studyAline N Zouk, Swati Gulati, Dongqi Xing, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 11, 2019
Velocity Transfer Function In The Right Pulmonary Artery And Impaired Cardiopulmonary Reserve In COPDOleg F Sharifov, Thomas S Denney, J Michael Wells, et al.
International Journal of Molecular Sciences|May 12, 2019
Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot StudySwati Gulati, J Michael Wells, Gisel P Urdaneta, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 14, 2018
The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort studySwati Gulati, Aline N Zouk, Jonathan P Kalehoff, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 28, 2023
Evaluating the consistency with guideline recommendations for diagnosis and management of idiopathic pulmonary fibrosis in non-academic settingsJoao De Andrade, Tracy Luckhardt, Sushilkumar Sonavane, et al.
Pageof 3